HOOKIPA Pharma Inc (HOOK)
0.7905
+0.04
(+5.16%)
USD |
NASDAQ |
May 31, 16:00
0.83
+0.04
(+5.00%)
Pre-Market: 20:00
HOOKIPA Pharma Cash from Investing (Quarterly): -0.116M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.116M |
December 31, 2023 | -0.422M |
September 30, 2023 | -3.018M |
June 30, 2023 | -0.445M |
March 31, 2023 | -0.274M |
December 31, 2022 | -0.599M |
September 30, 2022 | -0.958M |
June 30, 2022 | -1.632M |
March 31, 2022 | -1.828M |
December 31, 2021 | -5.141M |
September 30, 2021 | -2.486M |
June 30, 2021 | -4.624M |
March 31, 2021 | -0.33M |
Date | Value |
---|---|
December 31, 2020 | -0.505M |
September 30, 2020 | -0.625M |
June 30, 2020 | -1.042M |
March 31, 2020 | -0.199M |
December 31, 2019 | -1.046M |
September 30, 2019 | -0.362M |
June 30, 2019 | -0.191M |
March 31, 2019 | -0.40M |
December 31, 2018 | -0.25M |
September 30, 2018 | -0.28M |
June 30, 2018 | -1.358M |
March 31, 2018 | -0.262M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.141M
Minimum
Dec 2021
-0.116M
Maximum
Mar 2024
-1.292M
Average
-0.612M
Median
Cash from Investing (Quarterly) Benchmarks
Merck & Co Inc | -1.376B |
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 1.00M |
Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -24.16M |
Cash from Financing (Quarterly) | -0.135M |
Free Cash Flow | -82.83M |
Free Cash Flow Per Share (Quarterly) | -0.1927 |
Free Cash Flow to Equity (Quarterly) | -24.30M |
Free Cash Flow to Firm (Quarterly) | -24.27M |
Free Cash Flow Yield | -97.15% |